Turkey Company Roundup: Roche Case Reopens, Sanofi Starts Exports
This article was originally published in PharmAsia News
Executive Summary
The Supreme Court in Turkey has cancelled a statute of limitations decision in a Roche legal case, with some ex-managers and bureaucrats to be retried. Meanwhile, Sanofi Turkey has become the first pharmaceutical company to export antibiotics to Japan from a production site in Turkey, the AIFD has elected a chairman, and Lilly has made new appointments.
You may also be interested in...
Pricing Concerns Delaying Sanofi’s Turkey Insulin Investment?
Despite the political turmoil, Sanofi appears keen to invest in the local manufacturing of an insulin product in Turkey if the government “opens the way”, but is holding off over pricing worries.
Medtech Procurement A Victim Of Turkey’s Ongoing Economic Troubles
The devaluation of the Turkish Lira since May is making imports of medical devices more expensive and putting hospital procurement under renewed pressure. The local medtech industry associations TUMDEF and ARTED describe the problems ̶ and the solutions ̶ to Medtech Insight.
A Bright Moment At Last In Turkish Medtech Debt Payments Saga
Turkish medtechs’ demands for payment of their outstanding hospital debts went unheeded in 2021, but the government has finally started a payment process. It is not evenly applied, and has started in a small way, but the industry feels encouraged on more than one count.